EMR
February 7, 2024 - AI Summary
Overvalued by 69.9% based on the discounted cash flow analysis.
Market cap | $64.80 Billion |
---|---|
Enterprise Value | $73.58 Billion |
Dividend Yield | $2.0733 (1.83%) |
Earnings per Share | $19.21 |
Beta | 0.88 |
Outstanding Shares | 570,800,000 |
Avg 30 Day Volume | 2,322,118 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 5.88 |
---|---|
PEG | -6.26 |
Price to Sales | 4.05 |
Price to Book Ratio | 3.04 |
Enterprise Value to Revenue | 4.63 |
Enterprise Value to EBIT | 29.43 |
Enterprise Value to Net Income | 6 |
Total Debt to Enterprise | 0.15 |
Debt to Equity | 0.53 |
No data
No data